[go: up one dir, main page]

GR3035135T3 - Poultry vaccine containing infections bronchitis virus serotype 4/91. - Google Patents

Poultry vaccine containing infections bronchitis virus serotype 4/91.

Info

Publication number
GR3035135T3
GR3035135T3 GR20000402819T GR20000402819T GR3035135T3 GR 3035135 T3 GR3035135 T3 GR 3035135T3 GR 20000402819 T GR20000402819 T GR 20000402819T GR 20000402819 T GR20000402819 T GR 20000402819T GR 3035135 T3 GR3035135 T3 GR 3035135T3
Authority
GR
Greece
Prior art keywords
bronchitis virus
vaccine containing
virus serotype
poultry vaccine
infections bronchitis
Prior art date
Application number
GR20000402819T
Other languages
English (en)
Inventor
Jane Kathleen Alexandra Cook
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of GR3035135T3 publication Critical patent/GR3035135T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
GR20000402819T 1993-07-30 2000-12-21 Poultry vaccine containing infections bronchitis virus serotype 4/91. GR3035135T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93306033 1993-07-30
EP19940305561 EP0639640B1 (en) 1993-07-30 1994-07-27 Poultry vaccine containing infections bronchitis virus strain 4/91

Publications (1)

Publication Number Publication Date
GR3035135T3 true GR3035135T3 (en) 2001-04-30

Family

ID=8214489

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000402819T GR3035135T3 (en) 1993-07-30 2000-12-21 Poultry vaccine containing infections bronchitis virus serotype 4/91.

Country Status (9)

Country Link
US (2) US5750113A (el)
EP (1) EP0639640B1 (el)
JP (1) JP3650634B2 (el)
AT (1) ATE196773T1 (el)
DE (1) DE69426051T2 (el)
DK (1) DK0639640T3 (el)
ES (1) ES2152292T3 (el)
GR (1) GR3035135T3 (el)
PT (1) PT639640E (el)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2152292T3 (es) * 1993-07-30 2001-02-01 Akzo Nobel Nv Vacuna para aves de corral que contiene el virus de la bronquitis infecciosa 4/91.
ES2341841T3 (es) * 2000-02-29 2010-06-29 Wyeth Llc Proteccion in ovo contra la bronquitis infecciosa.
US20010046500A1 (en) * 2000-02-29 2001-11-29 Berend Jongsma In ovo protection against infectious bronchitis
US20040151765A1 (en) * 2001-09-18 2004-08-05 Ritchie Branson W. Methods and compositions for wound management
US20070003508A1 (en) 2005-07-01 2007-01-04 Wooley Richard E Methods and compositions for promoting wound healing
US20040208842A1 (en) * 2001-09-18 2004-10-21 Ritchie Branson W. Antimicrobial cleansing compositions and methods of use
US6605460B1 (en) * 2000-09-22 2003-08-12 University Of Minnesota Avian pneumovirus vaccine
US7217420B2 (en) * 2002-07-13 2007-05-15 The University Of Georgia Research Foundation, Inc. Mycoplasma gallisepticum formulation
DE60316701T2 (de) * 2002-09-18 2008-07-17 Intervet International B.V. Hühner-astrovirus typ 2
US6605283B1 (en) 2002-11-01 2003-08-12 The United States Of America As Represented By The Secretary Of Agriculture Nucleotide sequence for the Avian Metapneumovirus (Colorado) attachment glycoprotein gene
US6977079B2 (en) * 2003-01-17 2005-12-20 Regents Of The University Of Minnesota Avian pneumovirus vaccine
US7291342B2 (en) * 2003-05-19 2007-11-06 Intervet International B.V. Infectious bronchitis virus vaccine
BRPI0415816A (pt) 2003-10-31 2006-12-26 Univ British Columbia composição, bactéria ou um preparado da mesma, método para detectar a presença de um patógeno de a/e em uma amostra, método para provocar uma resposta imunológica contra um patógeno de a/e ou um componente do mesmo em um animal, método para reduzir a colonização de um patógeno de a/e em um animal, método para reduzir a disseminação de um patógeno de a/e em um animal, método para o tratamento ou a prevenção da infecção por um patógeno de a/e, método para atenuar a virulência de um patógeno de a/e, método para a seleção de um composto que atenue a virulência de um patógeno e a/e, método para a produção de um polipeptìdio de patógeno de a/e, polipeptìdio recombinante, molécula de ácido nucléico isolada, vetor, célula hospedeira, uso da composição e kit
BRPI0417880A (pt) * 2003-12-23 2007-04-27 Intervet Int Bv vacina de combinação para a proteção de aves domésticas contra ornithobacterium rhinotracheale, uso de uma cepa de ornithobacterium rhinotracheale superatenuada viva e um vìrus de aves domésticas atenuado, método para a preparação de uma vacina de combinação, e, kit de vacinação
WO2005091967A2 (en) * 2004-03-03 2005-10-06 University Of Georgia Research Foundation, Inc. Methods and compositions for ophthalmic treatment of fungal and bacterial infections
MX2009012924A (es) 2007-06-08 2010-03-25 Australian Poultry Crc Pty Ltd Toxina clostridial netb.
JP4935761B2 (ja) * 2008-06-02 2012-05-23 株式会社微生物化学研究所 家禽大腸菌症ワクチン
AR072976A1 (es) * 2008-08-08 2010-10-06 Wyeth Corp Virus de bronquitis infecciosa (ib) aislado, composicion de vacuna y metodo para preparar un virus de bronquitis infecciosa (ib) atenuado vivo
KR101092977B1 (ko) 2009-03-09 2011-12-26 대한민국 닭전염성 기관지염 바이러스 및 이를 포함하는 닭전염성 기관지염 백신
CN108653724B (zh) * 2017-04-01 2020-11-27 普莱柯生物工程股份有限公司 一种用于预防禽减蛋综合征的疫苗组合物、及其制备方法和应用
US11224649B2 (en) * 2018-10-31 2022-01-18 Boehringer Ingelheim Vetmedica Gmbh 4/91 IBV vaccine with heterologous spike protein
CN109628412B (zh) * 2018-12-27 2021-11-02 山东省农业科学院家禽研究所（山东省无特定病原鸡研究中心） 一株鸡传染性支气管炎病毒毒株及其应用
CN112048006B (zh) * 2020-09-08 2021-04-27 扬州大学 一种替代中和效力测定的elisa方法及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2801M (fr) * 1963-05-20 1964-09-21 Pierre Lepine Vaccins dits interférentiels contre les maladies a virus.
USRE31830E (en) * 1979-11-13 1985-02-12 Gist-Brocades N.V. Infectious bronchitis vaccine for poultry
US4357320A (en) * 1980-11-24 1982-11-02 Gist-Brocades N. V. Infectious bronchitis vaccine for poultry
PT72077B (en) * 1979-11-30 1981-09-29 Gist Brocades Nv Infectious bronchitis vaccines for poultry and process forthe preparation of such vaccines
USRE34013E (en) * 1979-11-30 1992-07-28 Gist-Brocades N.V. Infectious bronchitis vaccine for poultry
USRE32423E (en) * 1979-11-30 1987-05-19 Gist-Brocades N.V. Infectious bronchitis virus strain
US4500638A (en) * 1979-11-30 1985-02-19 Gist-Brocades N.V. Infectious bronchitis virus strain
EP0073856A1 (en) * 1981-08-28 1983-03-16 Gist-Brocades N.V. Infectious-bronchitis vaccines for poultry, combined infectious-bronchitis vaccines, process for preparing such vaccines, process for preventing infectious bronchitis and infectious-bronchitis virus strain
GB2114438A (en) * 1982-02-05 1983-08-24 Akzo Nv Infectious bronchitis vaccines
US4530831A (en) * 1982-11-02 1985-07-23 Akzo N.V. Infectious Bursal Disease vaccine
GB8431253D0 (en) * 1984-12-11 1985-01-23 Glaxo Group Ltd Biological preparations
US5032520A (en) * 1985-03-29 1991-07-16 National Research Development Corporation DNA sequences encoding infectious bronchitis virus spike protein
ATE66818T1 (de) * 1985-07-18 1991-09-15 Duphar Int Res Impfstoffe fuer einen tag alte huehner gegen die infektioese bronchitis.
US4824668A (en) * 1987-03-09 1989-04-25 Sterwin Laboratories Inc. Attenuated infectious bursal disease virus strain and vaccine therefrom
DE3878982T2 (de) * 1987-05-21 1993-07-22 Know How Licensors Ltd Abgeschwaechtes virus und impfstoffe davon zur verwendung gegen infektionen bei gefluegel, verursacht durch truthahn-rhinotracheitis-virus.
US4867975A (en) * 1988-01-27 1989-09-19 University Of Delaware Live attenuated temperature-sensitive avian infectious bronchitis virus vaccines and preparation and use thereof
ES2152292T3 (es) * 1993-07-30 2001-02-01 Akzo Nobel Nv Vacuna para aves de corral que contiene el virus de la bronquitis infecciosa 4/91.

Also Published As

Publication number Publication date
US6086892A (en) 2000-07-11
DE69426051T2 (de) 2001-05-10
JPH07147974A (ja) 1995-06-13
ES2152292T3 (es) 2001-02-01
EP0639640A1 (en) 1995-02-22
DE69426051D1 (de) 2000-11-09
US5750113A (en) 1998-05-12
EP0639640B1 (en) 2000-10-04
JP3650634B2 (ja) 2005-05-25
DK0639640T3 (da) 2001-01-02
PT639640E (pt) 2001-03-30
ATE196773T1 (de) 2000-10-15

Similar Documents

Publication Publication Date Title
GR3035135T3 (en) Poultry vaccine containing infections bronchitis virus serotype 4/91.
PL304419A1 (en) Urease based vaccine against heliobacter infections
MX9804965A (es) Estabilizantes para vacunas activas.
HU9601466D0 (en) Adjuvants for viral vaccines
AU1747688A (en) Canine coronavirus vaccine
PT838222E (pt) Composicoes de vacina compreendendo imunogenios inactivados e virus da anemia dagalinha (cav) vivos
TW340873B (en) Chicken anaemia agent vaccine
NZ335050A (en) Helicobacter pylori live vaccine
ES8403319A1 (es) Nuevas vacunas contra la bronquitis infecciosa.
WO1995012682A3 (en) Viral vector with bovine viral diarrhea virus (bvdv) antigens
AU3478393A (en) Vaccine containing acemannan as an adjuvant
WO1994000586A3 (fr) Mutants et vaccins du virus de la rhinotracheite infectieuse bovine
AU1521492A (en) Recombinant varicella-zoster virus and process for constructing same
AU3115189A (en) Live combination vaccine
SE9604322D0 (sv) Bacterial antigens and vaccine compositions II
ZA908189B (en) Infectious bronchitis virus vaccine
SG52780A1 (en) Vaccine against mumps containing a jeryl-lynn virus strain
NZ510130A (en) Chicken anaemia viruses of low pathogenicity
ZA924654B (en) Attenuated revertant serotype 1 marek's disease vaccine